These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 373998)

  • 1. The effects of D-amphetamine on dopaminergic regulated mechanisms of physiological and behavioral thermoregulation.
    Yehuda S
    Curr Dev Psychopharmacol; 1979; 5():125-71. PubMed ID: 373998
    [No Abstract]   [Full Text] [Related]  

  • 2. Paradoxical effects of d-amphetamine on behavioral thermoregulation: possible mediation by brain dopamine.
    Yehuda S; Wurtman RJ
    J Pharmacol Exp Ther; 1974 Jul; 190(1):118-22. PubMed ID: 4367895
    [No Abstract]   [Full Text] [Related]  

  • 3. Various effects of d-amphetamine in rats with selective lesions of brain noradrenaline - containing neurons or treated with penfluridol.
    Quattrone A; Bendotti C; Recchia M; Samanin R
    Commun Psychopharmacol; 1977; 1(6):525-31. PubMed ID: 564765
    [No Abstract]   [Full Text] [Related]  

  • 4. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
    Pavón N; Vidal L; Alvarez P; Blanco L; Torres A; Rodríguez A; Macías R
    Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
    Cooper BR; Breese GR
    Adv Biochem Psychopharmacol; 1974; 12(0):353-68. PubMed ID: 4609223
    [No Abstract]   [Full Text] [Related]  

  • 6. Brain dopamine, D-amphetamine and thermoregulation in rats.
    Yehuda S
    Isr J Med Sci; 1976 Sep; 12(9):1063-4. PubMed ID: 1002434
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopaminergic neurons in the nigro-striatal and mesolimbic pathways: mediation of specific effects of D-amphetamine.
    Yehuda S; Wurtman RJ
    Eur J Pharmacol; 1975 Feb; 30(2):154-8. PubMed ID: 1168575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral implications of dopaminergic neurons in the mesolimbic system.
    Iversen SD; Koob GF
    Adv Biochem Psychopharmacol; 1977; 16():209-14. PubMed ID: 560790
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of amphetamine and cocaine treatment on c-Fos, Jun-B, and Krox-24 expression in rats with intrastriatal dopaminergic grafts.
    Rodriguez JJ; Montaron MF; Aurousseau C; Le Moal M; Abrous DN
    Exp Neurol; 1999 Sep; 159(1):139-52. PubMed ID: 10486183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects of a lesion in the ventral mesencephalic tegmentum: evidence for involvement of A10 dopaminergic neurons.
    Le Moal M; Stinus L; Simon H; Tassin JP; Thierry AM; Blanc G; Glowinski J; Cardo B
    Adv Biochem Psychopharmacol; 1977; 16():237-45. PubMed ID: 883544
    [No Abstract]   [Full Text] [Related]  

  • 11. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
    Izzo E; Sanna PP; Koob GF
    Pharmacol Biochem Behav; 2005 Aug; 81(4):701-8. PubMed ID: 16005056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interchangeability of stress and amphetamine in sensitization.
    Antelman SM; Eichler AJ; Black CA; Kocan D
    Science; 1980 Jan; 207(4428):329-31. PubMed ID: 7188649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral and neurochemical correlates of repeated d-amphetamine administration.
    Segal DS
    Adv Biochem Psychopharmacol; 1975; 13():247-62. PubMed ID: 1171583
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduction of dopaminergic supersensitivity by a single dose of amphetamine.
    Haracz JL; Tseng LF
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(2):131-3. PubMed ID: 6106902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditioned dopaminergic activity.
    Schiff SR
    Biol Psychiatry; 1982 Feb; 17(2):135-54. PubMed ID: 7200377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic lithium treatment and dopamine-mediated behavior.
    Ebstein RP; Eliashar S; Belmaker RH; Ben-Uriah Y; Yehuda S
    Biol Psychiatry; 1980 Jun; 15(3):459-67. PubMed ID: 7189675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amphetamine behavioral toxicity: rotational behavior after chronic intrastriatal infusion.
    Dougherty GG; Ellinwood EH
    Biol Psychiatry; 1981 May; 16(5):479-88. PubMed ID: 7196774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects of dopamine agonists increase with age.
    Smith RC; Leelavathi DE; Lauritzen AM
    Commun Psychopharmacol; 1978; 2(1):39-43. PubMed ID: 566185
    [No Abstract]   [Full Text] [Related]  

  • 19. A neuropharmacological analysis of central nervous system catecholamine systems in development protein malnutrition.
    Leahy JP; Stern WC; Resnick O; Morgane PJ
    Dev Psychobiol; 1978 Jul; 11(4):361-70. PubMed ID: 566687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron deficiency-induced circadian rhythm reversal of dopaminergic-mediated behaviours and thermoregulation in rats.
    Youdim MB; Yehuda S; Ben-Uriah Y
    Eur J Pharmacol; 1981 Sep; 74(4):295-301. PubMed ID: 7197630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.